[{"indications": "Indications\u00a0enhance permeation of subcutaneous or intramuscular injections, local anaesthetics and subcutaneous infusions; promote\r\nresorption of excess fluids and blood", "name": "HYALURONIDASE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "10 Musculoskeletal and joint diseases", "10.3 Drugs for the treatment of soft-tissue disorders and topical pain\r\nrelief", "10.3.1 Enzymes", "Hyaluronidase"], "cautions": "Cautions\u00a0infants or elderly (control speed and total volume\r\nand avoid overhydration especially in renal impairment)", "side-effects": "Side-effects\u00a0oedema; rarely local irritation,\r\ninfection, bleeding, bruising; occasional severe allergy (including\r\nanaphylaxis)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/17504.htm", "doses": ["With subcutaneous or intramuscular injection, 1500\u00a0units dissolved directly in solution to be injected (ensure\r\ncompatibility)", "With local anaesthetics, 1500\u00a0units mixed\r\nwith local anaesthetic solution (ophthalmology, 15\u00a0units/mL)", "Hypodermoclysis, 1500\u00a0units dissolved in 1\u00a0mL water for injections\r\nor 0.9% sodium chloride injection, administered\r\nbefore start of 500\u20131000\u00a0mL infusion fluid", "Extravasation (see notes above) or haematoma, 1500\u00a0units dissolved in 1\u00a0mL\r\nwater for injections or 0.9% sodium chloride injection,\r\ninfiltrated into affected area (as soon as possible after extravasation)"]}]